Prognostic value of end-of-induction PET response after first-line immunochemotherapy for follicular lymphoma (GALLIUM): secondary analysis of a randomised, phase 3 trial - Trotman, J; Barrington, S F; Belada, D (The Lancet Oncology, 2018)
et al.